Cupertino, CA—Great news for developers, patients, and healthcare professionals: Apple’s CareKit modules are officially up and ready for use on GitHub, and three apps that utilize the CareKit platform are available for download—Iodine for mental health, One Drop for diabetes management, and Glow for reproductive health. To refresh your memory, Apple CareKit allows developers to help patients collect health data through apps on their smartphone with four modules. What has yet to be seen is the reaction from health care professionals; will this fit into their over-scheduled daily routine? Will they see the benefit? The discussion rages on about privacy concerns as well, but many are optimistic about the potential of this technology.

“No company is going to solve the problems of health care tomorrow,” says primary care doctor Jordan Shlain, who has advised Apple in the past. “Apple is helping facilitate rapid prototyping, so we can figure out what works and what doesn’t in this broken, high-regulated system.”

Why this matters:

Mobile health is on the rise, and CareKit has the potential to revolutionize the approach to patient care from the onset of symptoms, to treatment, to follow-up care once those patients leave the hospital or clinic setting. We’ll be following closely to check out the data as it pours in, to get a better understanding of the impact that CareKit is making both for patients and care teams. Read more about the launch here.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.